HPV Transmission

3 Responses to “Is There A Vaccine For Men That Carry The Hpv Bacteria?”

1. tarnishe Says:
   February 12th, 2010 at 10:12 pm

   The maker of Gardasil is asking the FDA to approve the vaccine for me.
   HPV is a virus and the vaccine Gardasil only prevents 4 HPV types two low risk HPV types 6 and 11 and two high risk HPV types 16 and 18. The vaccine does not prevent all genital HPV types. They are 40 genital HPV types. The vaccine does not prevent all HPV types that have been linked to cervical, vulva, vaginal and anal cancer.
   The vaccine is most effective if given before any sex.
   Giving the vaccine to girls only…address only half the problem…
   A girl can be a virgin when she marries…and acquire HPV for her husband…if he has engaged in sex before. Many men and women do acquire HPV at first sex.
   About 3,700 women in the US die each year due to cervical cancer…
   In some situations HPV can be a problem for men…and it seems that men may have a greater risk of oral cancers due to high risk HPV types that affect the oral area. The areas of oral and anal cancers and HPV have indicated that it is important to vaccinate males also.
   Gardasil maker pitches the vaccine for boys
   For girls, the debate was about sex. Now, it’s about cost and safety. A double
   standard?
   By Rob Stein
   Washington Post
   Posted: 04/01/2009 12:01:00 AM CDT
   WASHINGTON — When a vaccine designed to protect girls against a sexually
   transmitted virus arrived three years ago, the debate centered on one question:
   Would the shots make girls more likely to have sex?
   The vaccine’s maker now is trying to obtain approval to sell a vaccine for boys,
   and the debate focuses on entirely different issues: Is it worth the money, and
   is it safe and effective?
   “We are still more worried about the promiscuity of girls than the promiscuity
   of boys,” said Susan Reverby, a professor of women’s studies and medical history
   at Wellesley College. “There’s still that double standard.”
   Industry observers say the discussion illustrates how the interplay of
   political, economic, scientific, regulatory and social factors influences
   medical care.
   In the case of the vaccine, it reflects a strategic tack by Gardasil critics,
   growing concern about health-care costs, fears about whether treatments are
   adequately vetted and stubborn gender biases.
   “There is the cost, the safety, the boys-versus-girls,” said Susan Wood, a
   professor of public health at George Washington University. “These are some of
   the complexities that are going to have to be addressed.”
   Gardasil protects against the human papillomavirus, or HPV, the most common
   sexually transmitted infection. HPV causes genital warts and, in women, can lead
   to cervical cancer, a disease that strikes about 10,000 American women a year
   and kills about 3,700.
   Diane Harper, a
   ______________________________________…
   Advertisement
   ______________________________________…
   professor of medicine at the University of Missouri at Kansas City who helped
   study the vaccine in women for Merck, questions whether the benefits for boys
   are worth even small risks.
   “There’s probably enough data to say it probably is effective for the prevention
   of genital warts. They’re not fun, but they’re not at the same level as cancer
   or lethal infectious diseases,” Harper said.
   But besides protecting against genital warts in males, it averts less common
   malignancies that HPV can cause: penile and anal cancer, as well as cancer of
   the mouth and throat. The virus causes at least 250,000 new cases of genital
   warts and an estimated 7,500 cancers in males, resulting in about 1,000 deaths
   each year. Plus, vaccinating boys and men would help prevent the spread of the
   virus to their sexual partners.
   “By vaccinating men as well as women, you reduce the amount of virus that is out
   there that can be transmitted,” said Richard Haupt, who leads the HPV vaccine
   program at Merck & Co., which makes Gardasil. “There will be a benefit not only
   to men themselves, but to their partners and future partners.”
   After the Food and Drug Administration approved the vaccine for girls as young
   as 9 in 2006, medical authorities recommended they receive it at age 11 or 12
   before they start having sex. Critics worried that vaccinating children would
   send a subtle signal that their parents assumed they would become sexually
   active.
   Merck also launched an aggressive marketing campaign to persuade states to add
   the vaccine to the list of those required for children to attend school. But the
   company abandoned the strategy in the face of an intense backlash from those who
   said the decision should be left to parents.
   In December, Merck asked the FDA to approve the vaccine for males ages 9 to 26.
   In February, it presented the results of a large study that tested the vaccine
   in men to the federal Centers for Disease Control and Prevention’s Advisory
   Committee on Immunization Practices. The committee’s recommendations influence
   which vaccines schools require and whether private insurance companies and state
   programs will

2. jellybea Says:
   February 13th, 2010 at 4:05 am

   I’m not 100% sure, but there’s no way to tell if a man carries HPV. http://www.cdc.gov/STD/HPV/STDFact-HPV.h…
   Women need to get vaccinated because certain strains of HPV can cause cervical cancer, which doesn’t have a high survival rate.

3. frugalmo Says:
   February 13th, 2010 at 7:12 am

   HPV is a virus not a bacteria- and certain strains of HPV can cause cervical cancer- they are now doing studies on a vaccine for men because they are finding it causes cancer in men too.

Leave a Reply